Peijia Medical Limited (HKG:9996)
Hong Kong
· Delayed Price · Currency is HKD 4.680
-0.070 (-1.47%)
Mar 12, 2025, 4:08 PM HKT
Peijia Medical Revenue
Peijia Medical had revenue of 301.20M CNY in the half year ending June 30, 2024, with 153.54% growth. This brings the company's revenue in the last twelve months to 517.46M, up 44.98% year-over-year. In the year 2023, Peijia Medical had annual revenue of 441.13M with 75.86% growth.
Revenue (ttm)
517.46M CNY
Revenue Growth
+44.98%
P/S Ratio
5.73
Revenue / Employee
531.82K CNY
Employees
973
Market Cap
3.06B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| JD Health International | 61.89B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| WuXi Biologics | 18.39B |
| Alibaba Health Information Technology | 31.39B |
| Innovent Biologics | 8.01B |
| Akeso | 2.01B |
| Sinopharm Group | 634.32B |